Siyi Li
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Genetics
- Topics
- Cancer Cells and Metastasis (5 papers)MicroRNA in disease regulation (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Journals
- ACS NanoPLoS ONEFood Chemistry
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Siyi Li
28 papers receiving 648 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 349
- Oncology 257
- Cancer Research 188
- Pulmonary and Respiratory Medicine 60
- Genetics 51
Countries citing papers authored by Siyi Li
This map shows the geographic impact of Siyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siyi Li more than expected).
Fields of papers citing papers by Siyi Li
This network shows the impact of papers produced by Siyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siyi Li. The network helps show where Siyi Li may publish in the future.
Co-authorship network of co-authors of Siyi Li
This figure shows the co-authorship network connecting the top 25 collaborators of Siyi Li. A scholar is included among the top collaborators of Siyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siyi Li. Siyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 5 | |
| 12 | 7 | |
| 13 | 35 | |
| 14 | 27 | |
| 15 | 38 | |
| 16 | 148 | |
| 17 | 80 | |
| 18 | 39 | |
| 19 | 67 | |
| 20 | [Influence of celecoxib on invasiveness of human high-metastatic nasopharyngeal carcinoma cell line CNE-2Z]. | 4 |
About Siyi Li
Siyi Li is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Developmental Biology, having authored 32 papers that have together received 650 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (188 citations), Oncology (257 citations) and Otorhinolaryngology (23 citations). Siyi Li has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Weiren Luo, Kai‐Tai Yao, Xubin Deng, Yanfen Ye, Bailu Peng, Weiyi Fang, Aibing Wu, Kai‐Tai Yao, Qianbing Zhang and Zhixiong Yang. Their work appears in journals such as ACS Nano, PLoS ONE and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.